The End of Phase-Gated Trials: How ARPA-H's SURPASS Program Reengineers Biomedical R&D
Dr. Dereck Mush, MD, MBA
InSilicoTrials
Provides computational modeling and simulation software for virtual drug trials.
What they do
InSilicoTrials offers a cloud based platform that hosts computational modeling and simulation tools. Pharmaceutical and medical device companies use the system to run virtual clinical trials, helping them predict drug safety and efficacy before physical testing begins.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Clinical trial simulation
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Trieste, Italy
- Region
- Europe
- Founded
- 2018
- Total funding
- $10M raised
Notable investors: UV T-Growth, Selected Pioneers, Launchpad.
Also in Pharma & Drug Discovery
Related on The Signal
Dr. Dereck Mush, MD, MBA
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA
Is AI Drug Discovery Actually Working? What the 2026 Clinical Trial Data Shows
Dr. Dereck Mush, MD, MBA
Decentralized and adaptive trial designs move from pilot to default in biotech development plans
Dr. Dereck Mush, MD, MBA